Triangular test applied to the clinical trial of azithromycin againstrelapses in Plasmodium vivax infections

Malaria Journal

Volumn 1, Issue , 2002, Pages 1-7

  Ranque, Stéphane ^a   Badiaga, Sékéné ^b   Delmont, Jean ^b   Brouqui, Philippe ^b  

^a INSERM   (France)

^b HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZADOSE; AZITHROMYCIN;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MALARIA; MALE; METHODOLOGY; NAUSEA; PHASE 2 CLINICAL TRIAL; PLASMODIUM VIVAX; RELAPSE; SEQUENTIAL ANALYSIS; TREATMENT OUTCOME; TRIANGULAR TEST;

EID: 34248340931     PISSN: 14752875     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2875-1-1     Document Type: Article

References (18)

1. Pocock SJ: Size of cancer clinical trials and stopping rules. Br J Cancer 1978, 38:757-766
2. Pocock SJ: Group sequential methods in the design and analysis of clinical trials. Biometrika 1977, 64:191-199
3. Lemeshow S, Taber S: Lot quality assurance sampling: single- and double-sampling plans. World Health Stat Q 1991, 44:115-132
4. Dodge HF, Roming HG: A method for obtaining and analysing sensitivity data. Bell System Technical Journal 1929, 8:613-631
5. Armitage P: Sequential medical trials. New York: Wiley & Sons 1975
6. Whitehead J: A unified theory for sequential clinical trials. Stat Med 1999, 18:2271-2286
7. Wald A: Sequential analysis. New York: Wiley 1947
8. Whitehead J: The design and analysis of sequential clinical trials, Chichester: John Wiley & Sons 1997
9. Bellissant E, Benichou J, Chastang C: Application of the triangular test to phase II cancer clinical trials. Stat Med 1990, 9:907-917
10. Bellissant E, Benichou J, Chastang C: Design and analysis of phase II trials in oncology with a group sequential method, the triangular test. Therapie 1991, 46:21-27
11. Walsh DS, Looareesuwan S, Wilairatana P, Heppner DG Jr, Tang DB, Brewer TG, Chokejindachai W, Viriyavejakul P, Kyle DE, Milhous WK, et al: Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand. J Infect Dis 1999, 180:1282-1287
12. Adak T, Sharma VP, Orlov VS: Studies on the Plasmodium vivax relapse pattern in Delhi, India. Am J Trop Med Hyg 1998, 59:175-179
13. Smoak BL, DeFraites RF, Magill AJ, Kain KC, Wellde BT: Plasmodium vivax infections in U.S. Army troops: failure of primaquine to prevent relapse in studies from Somalia. Am J Trop Med Hyg 1997, 56:231-234
14. Taylor WR, Richie TL, Fryauff DJ, Picarima H, Ohrt C, Tang D, Braitman D, Murphy GS, Widjaja H, Tjitra E, et al: Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia. Clin Infect Dis 1999, 28:74-81
15. Pukrittayakamee S, Clemens R, Chantra A, Nontprasert A, Luknam T, Looareesuwan S, White NJ: Therapeutic responses to antibacterial drugs in vivax malaria. Trans R Soc Trop Med Hyg 2001, 95:524-528
16. Puri SK, Singh N: Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys. Exp Parasitol 2000, 94:8-14
17. Wildfeuer A, Laufen H, Zimmermann T: Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions. Antimicrob Agents Chemother 1996, 40:75-79
18. Benichou J, Bellissant E, Chastang C: Analysis of phase II clinical trials in haematology and oncology: comparison of the triangular test to the usual methods. Stat Med 1991, 10:989-990